Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shun Saito

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Japanese Journal of Clinical Oncology|November 19, 2025
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort studyKosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, et al.
International Journal of Clinical Oncology|July 15, 2026
Real-world evaluation of primary prophylactic use of granulocyte colony-stimulating factor in patients with metastatic castration-sensitive prostate cancer treated with triplet therapyMasataka Kubo, Fumihiko Urabe, Kojiro Tashiro, et al.
International Journal of Clinical Oncology|May 20, 2024
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective studyShuhei Hara, Keiichiro Mori, Wataru Fukuokaya, et al.
Japanese Journal of Clinical Oncology|June 26, 2024
Associations between early changes in the neutrophil-to-lymphocyte ratio after radical nephroureterectomy and treatment outcomesShun Saito, Hidetsugu Takahashi, Yuji Yata, et al.
BJUI Compass|August 7, 2025
Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomyKenichi Hata, Yuma Goto, Masaki Hashimoto, et al.
International Journal of Clinical Oncology|October 20, 2023
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort studyHirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Japanese Journal of Clinical Oncology|November 19, 2025
Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort studyKosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, et al.
International Journal of Clinical Oncology|July 15, 2026
Real-world evaluation of primary prophylactic use of granulocyte colony-stimulating factor in patients with metastatic castration-sensitive prostate cancer treated with triplet therapyMasataka Kubo, Fumihiko Urabe, Kojiro Tashiro, et al.
International Journal of Clinical Oncology|May 20, 2024
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective studyShuhei Hara, Keiichiro Mori, Wataru Fukuokaya, et al.
Japanese Journal of Clinical Oncology|June 26, 2024
Associations between early changes in the neutrophil-to-lymphocyte ratio after radical nephroureterectomy and treatment outcomesShun Saito, Hidetsugu Takahashi, Yuji Yata, et al.
BJUI Compass|August 7, 2025
Bilateral vas deferens suturing to prevent inguinal hernias after radical prostatectomyKenichi Hata, Yuma Goto, Masaki Hashimoto, et al.
International Journal of Clinical Oncology|October 20, 2023
Real-world outcomes of adjuvant immunotherapy candidates with upper tract urothelial carcinoma: results of a multicenter cohort studyHirokazu Kagawa, Fumihiko Urabe, Yuria Kiuchi, et al.
Pageof 7